Skip to main content
SpringerLink
Log in

Opioids in cancer pain — which one is best?

  • Editorial
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wilder-Smith CH (1998) Pain treatment in multimorbid patients, the older population and other high-risk groups. Drug Safety 18:457–472

    Article  CAS  PubMed  Google Scholar 

  2. Mayer U (2000) Pharmacogenetics and adverse drug reactions. Lancet 356:1167–1771

    Article  Google Scholar 

  3. Davis MP, Walsh D (2000) Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer

    Google Scholar 

  4. Sarhill N, Walsh D, Nelson KA. Hydromorphone: pharmacology and clinical applications in cancer patients. Support Care Cancer

  5. Mercadante S, Fulfaro F, Dabbene M (2000) Methadone in treating tenesmus not responding to morphine escalation. Support Care Cancer

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nociception Research Group, Bubenbergplatz 11, CH-3011 Berne, Switzerland

    Clive H. Wilder-Smith

Authors
  1. Clive H. Wilder-Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clive H. Wilder-Smith.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilder-Smith, C.H. Opioids in cancer pain — which one is best?. Support Care Cancer 9, 71–72 (2001). https://doi.org/10.1007/s005200000228

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005200000228

Search

Navigation